| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_71b5b7d4e7a9697470ae7cebf6e03faf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3377bd324540504aaa3d0d4726b1ab89 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-217
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| filingDate |
2011-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7a9ee1a119cb8fc9d40881e4d8cb8e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63e8dc20cd3cde71da02f96441c0367f |
| publicationDate |
2012-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012028961-A2 |
| titleOfInvention |
Compositions and methods for treating friedreich's ataxia with interferon gamma |
| abstract |
Described herein are compositions and methods for treating Friedreich's Ataxia (FRDA) with interferon gamma. In some aspects, methods for increasing expression of frataxin in cells and for treating Friedreich's Ataxia are provided. In some additional aspects, methods increasing aconitase activity in cells are provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10041074-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016103223-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015023939-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3830115-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10426775-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10442779-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10758558-B2 |
| priorityDate |
2010-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |